Ajanta Pharmaceuticals Q2 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
3,001.8
41.50 (1.40%)
41.50 (1.40%)Volume8.27 K
Updated: Mon 25 Nov, 2024 | 15:56:58
NSE
2,996.736.65 (1.24%)
36.65 (1.24%)Volume1.35 L
Updated: Mon 25 Nov, 2024 | 15:44:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹1,186.64 Cr.(3.64%)
- Operating Profit₹302.43 Cr.(2.04%)
- Profit After Tax₹216.48 Cr.(-11.92%)
- Operating Margin25.49%(2.01%)
Note: Comparison is on YoY basis
Quarterly - Ajanta Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,186.64 | 1,021.04 | -% | 1,028.44 | -% |
| Selling/ General/ Admin Expenses Total | 260.96 | 213.21 | -% | 222.27 | -% |
| Depreciation/ Amortization | 34.39 | 33.18 | -% | 33.71 | -% |
| Other Operating Expenses Total | 327.18 | 274.62 | -% | 259.39 | -% |
| Total Operating Expense | 884.21 | 772.91 | -% | 771.49 | -% |
| Operating Income | 302.43 | 248.13 | -% | 256.95 | -% |
| Net Income Before Taxes | 290.24 | 269.04 | -% | 275.94 | -% |
| Net Income | 216.48 | 208.12 | -% | 195.30 | -% |
| Diluted Normalized EPS | 17.26 | 16.53 | -% | 15.50 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST